Maravai LifeSciences Holdings Inc (MRVI)
7.60
-0.12
(-1.55%)
USD |
NASDAQ |
Apr 18, 16:00
7.60
0.00 (0.00%)
After-Hours: 20:00
Maravai LifeSciences Holdings Shareholders Equity (Quarterly): 416.75M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 416.75M |
| September 30, 2023 | 519.29M |
| June 30, 2023 | 520.57M |
| March 31, 2023 | 521.52M |
| December 31, 2022 | 545.22M |
| September 30, 2022 | 503.76M |
| June 30, 2022 | 456.59M |
| March 31, 2022 | 382.56M |
| Date | Value |
|---|---|
| December 31, 2021 | 315.50M |
| September 30, 2021 | 302.64M |
| June 30, 2021 | 193.92M |
| March 31, 2021 | 112.61M |
| December 31, 2020 | 88.51M |
| September 30, 2020 | -52.57M |
| December 31, 2019 | 141.40M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-52.57M
Minimum
Sep 2020
545.22M
Maximum
Dec 2022
331.22M
Average
382.56M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| ModivCare Inc | 156.20M |
| Dyadic International Inc | 5.879M |
| Enveric Biosciences Inc | 1.956M |
| Monopar Therapeutics Inc | 5.588M |
| SeaStar Medical Holding Corp | -13.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.487B |
| Total Liabilities (Quarterly) | 697.57M |
| Debt to Equity Ratio | 1.258 |
| Current Ratio | 8.002 |
| Net Debt Paydown Yield | 0.10% |